BREVILLE GROUP LIMITED (BRG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BRG - BREVILLE GROUP LIMITED

Year End: June
GICS Industry Group : Retailing
Debt/EBITDA: 1.29
Index: ASX200 | ASX300 | ALL-ORDS

Breville is an Australian multinational manufacturer of kitchen products and small electrical appliances. Established in 1932, it became a listed company in 1999.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$27.23

21 Feb
2024

-0.030

OPEN

$27.21

-0.11%

HIGH

$28.20

388,467

LOW

$27.08

TARGET
$26.86 -1.4% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ABY . BWX . DSK . GUD . MYR . SSG . TRS .
FNARENA'S MARKET CONSENSUS FORECASTS
BRG: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx 77.2 81.2 xxx
DPS (cps) xxx 30.5 32.3 xxx
EPS Growth xxx 1.8% 5.1% xxx
DPS Growth xxx 1.7% 6.0% xxx
PE Ratio xxx N/A 33.7 xxx
Dividend Yield xxx N/A 1.2% xxx
Div Pay Ratio(%) xxx 39.5% 39.8% xxx

Dividend yield today if purchased 3 years ago: 1.04%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.12

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 13/09 - ex-div 15.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx77.2
DPS All xxxxxxxxxxxxxxx30.5
Sales/Revenue xxxxxxxxxxxxxxx1,478.6 M
Book Value Per Share xxxxxxxxxxxxxxx539.0
Net Operating Cash Flow xxxxxxxxxxxxxxx90.3 M
Net Profit Margin xxxxxxxxxxxxxxx7.45 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx15.93 %
Return on Invested Capital xxxxxxxxxxxxxxx11.90 %
Return on Assets xxxxxxxxxxxxxxx8.63 %
Return on Equity xxxxxxxxxxxxxxx15.93 %
Return on Total Capital xxxxxxxxxxxxxxx18.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx26.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx23 M
Long Term Debt xxxxxxxxxxxxxxx257 M
Total Debt xxxxxxxxxxxxxxx280 M
Goodwill - Gross xxxxxxxxxxxxxxx326 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx84 M
Price To Book Value xxxxxxxxxxxxxxx3.70

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx53.2 M
Capex % of Sales xxxxxxxxxxxxxxx3.60 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,191 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx116 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.6

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

14/02/2024

1

Buy

$28.30

3.93%

UBS reports Breville Group's disappointing interim performance, featuring all geographies in "softer" mode, comes as a suprise given recent industry feedback.

Gross profit and EBIT proved broadly in line with forecasts. The broker does note the result has been impacted by Bed Bath & Beyond, a major customer, going out of business.

UBS takes guidance from the impressive growth achieved over the past five years, and remains optimistic for FY25, and beyond. On the broker's numbers, EPS CAGR will be 15%-plus over FY24-FY27.

Buy. Target $28.30, down -30c.

FORECAST
UBS forecasts a full year FY24 EPS of 79.00 cents.
UBS forecasts a full year FY25 EPS of 91.00 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

BRG STOCK CHART